为心力衰竭患者提供视频教育:系统性审查和元分析
Shuri Nakao1, Hidehiro Someko2, Masatsugu Okamura3
1Division of Rehabilitation Medicine, Shimane University Hospital, 89-1 Enya-cho, Izumo, Shimane 693-8501, Japan; Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan.
Heart & lung : the journal of critical care
|May 24, 2025
概括
对心力衰竭 (HF) 患者的视频教育显示,对死亡率,住院和生活质量 (QOL) 有非常不确定的影响. 目前的证据表明,它可能不优于现有的高频管理策略.
科学领域:
- 心脏病学 心脏病学
- 医学教育 医学教育
- 基于证据的医学基于证据的医学.
背景情况:
- 心力衰竭 (HF) 管理需要有效的患者教育.
- 视频教育,利用成人学习原则,为提高患者理解和自我效能提供了一个有希望的模式.
- 对视频教育对HF死亡率,住院和生活质量 (QOL) 的影响缺乏全面的审查.
研究的目的:
- 系统地评估视频教育在改善心力衰竭患者临床结果方面的有效性.
- 综合证据关于视频教育对死亡率,HF住院和QOL的影响.
主要方法:
- 根据PRISMA 2020指南进行了系统审查.
- 包括随机对照试验,比较视频教育加常规护理与HF患者的常规护理单独.
- 从22项研究 (6614名患者) 的数据分析了死亡率,HF住院和QOL,以GRADE评估证据确定性.
主要成果:
- 关于视频教育对死亡率,HF住院和QOL的影响的证据确定性非常低.
- 死亡率和HF住院的风险比率,以及QOL的标准化平均差异,在统计学上并不显著,并且来自高度不确定的证据.
- 对于QOL结果,观察到很高的异质性 (I2 = 89%).
结论:
- 目前的证据表明,视频教育对心力衰竭管理的既定干预措施可能没有任何优势.
- 需要进一步进行高质量的研究,以澄清视频教育在改善HF患者治疗结果中的作用.
相关概念视频
01:30Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
01:29Heart Failure II: Pathophysiology
62
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
62
01:30Heart Failure IV: Classification and Diagnostic Evaluation
47
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
47
01:30Heart Failure VII: Nursing Interventions
149
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
149
01:29Cardiomyopathy V: Interprofessional Care
42
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
42
01:22Heart Failure VI: Adjunct Therapies
40
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
40